Who is sponsoring MALROT?

MALROT is sponsored by University Hospital, Montpellier.

What condition does MALROT study?

MALROT studies Postnatal Complication, Mesenteric Pregnancy.

What drugs are being tested in MALROT?

Interventions: Ultrasound exam, Fetal MRI, Postnatal abdominal ultrasound, Pediatric Follow up.

Last reviewed 2021-12-23 · How we verify

Prenatal Screening of Intestinal Malrotation With a Higher Risk of Volvulus. (MALROT)

NCT05148429 COMPLETED

Digestive malrotation is an anatomical anomaly of the positionning of the mesenteric vessels and the digestive tract that can lead in some form to a dangerous neonatal complication: intestinal volvulus. This requires emergency surgery with a risk of digestive resection. Visualizing during pregnancy the normal or abnormal anatomical positionning of the mesenteric vessels could make it possible to diagnose this malrotation and prevent the occurrence of this complication. The aim of the study is to study the neonatal outcome of fetus confirm to have an abnormal positionning of mesenteric vessels

Details

Lead sponsor	University Hospital, Montpellier
Status	COMPLETED
Enrolment	30
Start date	Wed Jan 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Postnatal Complication
Mesenteric Pregnancy

Interventions

Ultrasound exam
Fetal MRI
Postnatal abdominal ultrasound
Pediatric Follow up

Countries

France